JP2020519668A - 老化の阻害および老化関連障害の治療の方法 - Google Patents

老化の阻害および老化関連障害の治療の方法 Download PDF

Info

Publication number
JP2020519668A
JP2020519668A JP2019563174A JP2019563174A JP2020519668A JP 2020519668 A JP2020519668 A JP 2020519668A JP 2019563174 A JP2019563174 A JP 2019563174A JP 2019563174 A JP2019563174 A JP 2019563174A JP 2020519668 A JP2020519668 A JP 2020519668A
Authority
JP
Japan
Prior art keywords
mir
msc
mscs
aging
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019563174A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020519668A5 (en-20US4325121.pdf
Inventor
ブローディ,チャヤ
ブローディ,アーロン
Original Assignee
エグゾステム バイオテック リミテッド
エグゾステム バイオテック リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エグゾステム バイオテック リミテッド, エグゾステム バイオテック リミテッド filed Critical エグゾステム バイオテック リミテッド
Publication of JP2020519668A publication Critical patent/JP2020519668A/ja
Publication of JP2020519668A5 publication Critical patent/JP2020519668A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/7105Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
JP2019563174A 2017-05-16 2018-05-16 老化の阻害および老化関連障害の治療の方法 Pending JP2020519668A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762506661P 2017-05-16 2017-05-16
US62/506,661 2017-05-16
PCT/IL2018/050538 WO2018211510A1 (en) 2017-05-16 2018-05-16 Methods of inhibiting aging and treating aging-related disorders

Publications (2)

Publication Number Publication Date
JP2020519668A true JP2020519668A (ja) 2020-07-02
JP2020519668A5 JP2020519668A5 (en-20US4325121.pdf) 2021-07-26

Family

ID=64273428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019563174A Pending JP2020519668A (ja) 2017-05-16 2018-05-16 老化の阻害および老化関連障害の治療の方法

Country Status (6)

Country Link
US (1) US20200188440A1 (en-20US4325121.pdf)
EP (1) EP3624817A4 (en-20US4325121.pdf)
JP (1) JP2020519668A (en-20US4325121.pdf)
AU (1) AU2018270408A1 (en-20US4325121.pdf)
CA (1) CA3064064A1 (en-20US4325121.pdf)
WO (1) WO2018211510A1 (en-20US4325121.pdf)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220150024A (ko) * 2021-05-03 2022-11-10 고려대학교 산학협력단 융모막 추출물로부터 분리된 엑소좀을 유효성분으로 포함하는 골형성 촉진용 약학적 조성물
WO2023218804A1 (ja) * 2022-05-11 2023-11-16 克昭 團 膵機能活性化剤、抗老化剤、2型糖尿病の治療薬または予防薬、医薬品、化粧品および食品または飲料

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108753779B (zh) * 2018-06-07 2021-12-14 天津农学院 牛lncRNA-133a及在牛骨骼肌卫星细胞增殖分化调控中的应用和验证方法
TWI722400B (zh) * 2019-03-18 2021-03-21 佛教慈濟醫療財團法人 間質幹細胞之胞外泌體及其用途
CN111218451B (zh) * 2020-02-05 2021-08-10 华中农业大学 一种提高猪肌肉量的方法
KR102317052B1 (ko) * 2020-05-04 2021-10-25 주식회사 티에스셀바이오 태반 유래의 세포외 소포의 항염증 항바이러스 효과 조성물
CN111593114B (zh) * 2020-05-29 2022-12-20 广东医科大学附属医院 miR-122及其抑制剂在预防/治疗放射性脑损伤中的应用
JP6967308B1 (ja) * 2020-06-30 2021-11-17 国立大学法人高知大学 胎児付属物由来組織細胞培養上清を含む脳神経障害治療剤
CN112089733B (zh) * 2020-11-05 2021-03-12 广东赛尔生物科技有限公司 一种改造的脐带干细胞在制备抗衰老的药物组合物或者保健品中的用途
CN112280742A (zh) * 2020-11-05 2021-01-29 北京欣颂生物科技有限公司 干细胞制备的抗衰老的药物组合物或者保健品
CN113981074A (zh) * 2021-12-10 2022-01-28 石河子大学 一种与2型糖尿病相关的microRNA及其应用
CN115044543A (zh) * 2022-08-17 2022-09-13 山东卓东生物科技有限公司 一种提高衰老人体来源肌肉干细胞活性的方法
CN116926072B (zh) * 2023-05-04 2024-03-08 广州飞来爱生命科技有限公司 一种抑制神经干细胞诱导分化方法及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014191978A2 (en) * 2013-05-30 2014-12-04 Cells For Cells Chorion-derived mscs cells and conditioned media as inducer for angiogenesis application for the treatment of cardiac degeneration.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192988B2 (en) * 2004-10-22 2012-06-05 University Of Central Florida Research Foundation, Inc. Methods for increasing potency of adult mesenchymal stem cells
KR20120096793A (ko) * 2011-02-23 2012-08-31 (주)차바이오앤디오스텍 태반 유래 줄기세포를 포함한 면역반응억제용 조성물
JP6329911B2 (ja) * 2012-02-22 2018-05-23 ブレインステム バイオテック リミテッド 星状膠細胞作製のためのミクロrna
KR101555981B1 (ko) * 2013-05-01 2015-09-30 차의과학대학교 산학협력단 태반 유래 중간엽 줄기 세포, 또는 태반 유래 줄기세포로부터 유도된 신경 전구세포, 이를 포함하는 약학적 조성물, 질환 치료용 키트, 및 이를 이용하는 질환 치료방법
WO2015170347A2 (en) * 2014-05-09 2015-11-12 Reelabs Private Limited Foetal polymix of mesenchymal stem cells under hypoxic conditions for the treatment of clinical disorders
AU2015330855A1 (en) * 2014-10-09 2017-04-27 Celularity Inc. Placenta-derived adherent cell exosomes and uses thereof
CN104560869B (zh) * 2014-12-18 2018-02-23 江苏省北科生物科技有限公司 一种制备绒毛膜间充质干细胞的方法
US20160324898A1 (en) * 2015-05-04 2016-11-10 Stemedica International, Sa Compositions and methods for the treatment of alzheimer's disease
AU2017265937A1 (en) * 2016-05-16 2018-11-22 Exostem Biotec Ltd. Mesenchymal stem cell and use thereof for treatment of muscle injury and muscle-associated diseases
MX2019005127A (es) * 2016-11-03 2019-09-26 Exostem Biotec Ltd Poblaciones y productos de células madre mesenquimales y sus usos.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014191978A2 (en) * 2013-05-30 2014-12-04 Cells For Cells Chorion-derived mscs cells and conditioned media as inducer for angiogenesis application for the treatment of cardiac degeneration.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
変性疾患とは/コトバンク デジタル大辞泉, [ONLINE], INTERNET ARCHIVE:WAYBACK MACHINE,2016.03.29,[RET, JPN6022024416, ISSN: 0004977229 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220150024A (ko) * 2021-05-03 2022-11-10 고려대학교 산학협력단 융모막 추출물로부터 분리된 엑소좀을 유효성분으로 포함하는 골형성 촉진용 약학적 조성물
KR102523933B1 (ko) * 2021-05-03 2023-04-20 고려대학교 산학협력단 융모막 추출물로부터 분리된 엑소좀을 유효성분으로 포함하는 골형성 촉진용 약학적 조성물
WO2023218804A1 (ja) * 2022-05-11 2023-11-16 克昭 團 膵機能活性化剤、抗老化剤、2型糖尿病の治療薬または予防薬、医薬品、化粧品および食品または飲料

Also Published As

Publication number Publication date
CA3064064A1 (en) 2018-11-22
EP3624817A4 (en) 2021-05-19
US20200188440A1 (en) 2020-06-18
AU2018270408A1 (en) 2019-12-12
EP3624817A1 (en) 2020-03-25
WO2018211510A1 (en) 2018-11-22

Similar Documents

Publication Publication Date Title
US20210228647A1 (en) Mesenchymal stem cell and use thereof for treatment of muscle injury and muscle-associated diseases
JP2020519668A (ja) 老化の阻害および老化関連障害の治療の方法
US11220687B2 (en) Exosomes and micro-ribonucleic acids for tissue regeneration
Hamann et al. Nucleic acid delivery to mesenchymal stem cells: a review of nonviral methods and applications
US20200377854A1 (en) Generation of neural stem cells and motor neurons
KR101993027B1 (ko) 줄기 세포 마이크로입자
ES2705052T3 (es) Micropartículas de células madre y ARNmi
JP6329911B2 (ja) 星状膠細胞作製のためのミクロrna
KR20150059168A (ko) 줄기 세포 마이크로입자
EP1646714A2 (en) Method of altering cell properties by administering rna
Yousefi et al. Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: focus on mesenchymal stem cells and neuroprotection
US20230105667A1 (en) Mesenchymal stromal cells and extracellular vesicles for treating viral infections, inflammation, and tissue fibrosis
US20190015453A1 (en) MicroRNAS FOR THE GENERATION OF ASTROCYTES
da Silva Genetic engineering of Mesenchymal Stromal Cells to express anti-cancer proteins

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210514

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210514

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220621

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230131